CASTLE BIOSCIENCES INC (CSTL)
US14843C1053 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 82.95M | 98.84M | 122.90M | 329.60M | 409.90M | |||
| Marketable Securities | 156.26M | 144.26M | 135.70M | N/A | N/A | |||
| Receivables | 42.70M | 38.30M | 23.50M | 17.30M | 12.80M | |||
| Inventories | 7.64M | 7.94M | 4.00M | 2.00M | 2.20M | |||
| Other Current Assets | 6.22M | 6.29M | 6.20M | 4.80M | 4.80M | |||
| Total Current Assets | 295.78M | 295.63M | 292.30M | 353.70M | 429.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 44.87M | 37.74M | 26.50M | 16.90M | 7.10M | |||
| Goodwill | N/A | 10.69M | 10.70M | N/A | N/A | |||
| Intangibles | 115.09M | 106.64M | 115.70M | 88.90M | N/A | |||
| Other Non-Current Assets | 1.72M | 1.44M | 1.10M | 1.70M | 1.50M | |||
| Total Non-Current Assets | 162.73M | 157.71M | 155.00M | 108.90M | 9.70M | |||
| TOTAL ASSETS | 458.51M | 453.34M | 447.30M | 462.60M | 439.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 71.00K | 100.00K | 100.00K | 0.00 | |||
| Accrued Expenses | 20.30M | 33.85M | 29.40M | 20.60M | 12.10M | |||
| Accounts Payable | 9.32M | 10.27M | 4.70M | 2.50M | 2.10M | |||
| Other Current Liabilities | 2.34M | 3.48M | 1.80M | 1.70M | 6.70M | |||
| Total Current Liabilities | 31.96M | 47.67M | 36.10M | 24.90M | 20.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 10.02M | 25.00K | 100.00K | 100.00K | 0.00 | |||
| Deferred Taxes/Income | 206.00K | 206.00K | 400.00K | 600.00K | N/A | |||
| Other Non-Current Liabilities | 13.86M | 14.17M | 11.50M | 25.20M | 2.80M | |||
| Total Non-Current Liabilities | 24.09M | 14.40M | 12.10M | 25.90M | 2.70M | |||
| TOTAL LIABILITIES | 56.05M | 62.07M | 48.20M | 50.80M | 23.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -220.91M | -218.37M | -160.90M | -93.80M | -62.50M | |||
| Additional Paid In Capital | 623.45M | 609.48M | 560.40M | 505.50M | 478.20M | |||
| Common Shares | 28.00K | 27.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -111.00K | 136.00K | -400.00K | N/A | N/A | |||
| Shares Outstanding | 27.59M | 27.41M | 26.60M | 25.40M | 24.80M | |||
| Tangible Book Value per Share | 10.42 | 9.99 | 10.26 | 12.71 | 16.76 | |||
| Total Shareholders' Equity | 402.46M | 391.27M | 399.20M | 411.70M | 415.70M | |||
| TOTAL LIABILITIES AND EQUITY | 458.51M | 453.34M | 447.30M | 462.60M | 439.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.00 | 0.00 | 0.00 | N/A | |||
| Current Ratio | 9.25 | 6.20 | 8.10 | 14.20 | 20.56 | |||
| Return On Assets (ROA) | -6.72% | -12.68% | -15.00% | -6.77% | -2.34% | |||
| Return On Equity (ROE) | -7.65% | -14.69% | -16.81% | -7.60% | -2.48% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD